ELR-13514-10965
2 vaccinations
3 coded responses
23 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 480 / MI
- Registered
- 2021-01-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-07
Dose 1 — Pfizer-BioNTech
-
2021-01-08
Registered in v-safe
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-21
-
2021-01-26
Dose 2 — Pfizer-BioNTech
-
2021-01-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Chills, Joint pains, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-03-02
-
2021-03-09
Survey response — day 42, dose 2MedDRA: Arthralgia — Feeling: Good · Be unable to work, Be unable to do your normal daily activitiesFree text: joint painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-27
-
2021-07-27
Survey response — 6 months, dose 2MedDRA: Arthralgia, Autoimmune disorder, Hospitalisation, Hypoaesthesia, Neuropathy peripheral, Sinusitis — Feeling: Poor · Be unable to work or attend schoolFree text: Severe joint pain requiring steroids. Numbness of the hands and feet. Continuous sinus infection lasting 5 months. Sudden onset of autoimmune disease. Was hospitalized for two different times in the past 2 months. Severe neuropathy in hands and feet.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2022-01-26
Survey response — 12 months, dose 2MedDRA: Gait disturbance, Granulomatosis with polyangiitis, Mobility decreased, Mononeuritis, Myositis, Polyneuropathy, Radial nerve palsy — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Granulomatosis with polyangiitis itis without renal involvement, peripheral polyneuropathy, myositis of multiple sites, unspecified, unstable gait, mononeuritis of right upper extremity, right wrist drop, limited use of both hands and feetMedDRA releases: 2024-11 · check-in free text available
-
2022-01-26
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-01-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-07 | Pfizer-BioNTech | |
| 2 | 2021-01-26 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 5 — day 42, dose 2
Symptoms: joint pain
Release 9 — 6 months, dose 2
Symptoms: Severe joint pain requiring steroids. Numbness of the hands and feet. Continuous sinus infection lasting 5 months. Sudden onset of autoimmune disease. Was hospitalized for two different times in the past 2 months. Severe neuropathy in hands and feet. cut off by CDC
Release 11 — 12 months, dose 2
Symptoms: Granulomatosis with polyangiitis itis without renal involvement, peripheral polyneuropathy, myositis of multiple sites, unspecified, unstable gait, mononeuritis of right upper extremity, right wrist drop, limited use of both hands and feet
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Autoimmune disorder | ✓ | · | ✓ |
| SD | Gait disturbance | · | · | ✓ |
| SD | Granulomatosis with polyangiitis | · | · | ✓ |
| SD | Hospitalisation | ✓ | · | ✓ |
| SD | Hypoaesthesia | ✓ | · | ✓ |
| SD | Mobility decreased | · | · | ✓ |
| SD | Mononeuritis | · | · | ✓ |
| SD | Myositis | · | · | ✓ |
| SD | Neuropathy peripheral | ✓ | · | ✓ |
| SD | Polyneuropathy | · | · | ✓ |
| SD | Radial nerve palsy | · | · | ✓ |
| SD | Sinusitis | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release